Triamcinolone acetate
Sponsors
University of Sydney, Assiut University, Brixton Biosciences, Inc.
Conditions
Diabetic Macular OedemaGreater Trochanteric Pain SyndromeGreater Trochanteric Pain Syndrome of Both Lower LimbsLateral Hip PainOphthalmopathyOsteoarthritis (OA) of the Knee
Phase 2
A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema
CompletedNCT00148265
Start: 2005-04-30End: 2009-05-31Updated: 2010-06-23
Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
CompletedNCT00148330
Start: 2005-05-31End: 2008-07-31Updated: 2010-06-30
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)
CompletedNCT00167518
Start: 2002-03-31End: 2005-04-30Target: 70Updated: 2005-09-14
Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)
NCT04460001
Start: 2019-05-16End: 2021-12-01Target: 100Updated: 2020-07-07
Unknown Phase
INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE
Active, not recruitingNCT06700109
Start: 2024-11-19End: 2027-02-01Target: 263Updated: 2025-10-28
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain
RecruitingNCT07568015
Start: 2026-07-27End: 2029-11-01Target: 100Updated: 2026-09-11